DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

Correcting the acidosis did not protect the kidneys, and balanced fluid did not beat saline in 8,482 children with septic shock

SODa-BIC finds sodium bicarbonate makes no difference to major adverse kidney events in vasopressor-dependent metabolic acidosis; PRoMPT BOLUS settles the crystalloid question in paediatric septic shock; low-dose ketamine trims opioid requirement in ventilated adults; atropine vials are recalled for particulate contamination.

The edition in brief

SODa-BIC randomised 500 adults in 55 ICUs across seven countries with metabolic acidosis (pH under 7.30) receiving vasopressors to a titrated sodium bicarbonate infusion or 5% dextrose placebo for up to five hours. Major adverse kidney events at 30 days occurred in 40.2% versus 39.4% (adjusted difference 1.2 percentage points, 95% CI -7.1 to 9.4); renal-replacement therapy 16.8% versus 20.9%; in-hospital mortality by day 30 25.4% versus 24.0%. PRoMPT BOLUS randomised 9,041 children aged 2 months to under 18 years with suspected septic shock at 47 emergency departments in five countries to balanced fluid or 0.9% saline: major adverse kidney events at 30 days were 3.4% versus 3.0% (risk ratio 1.10, 95% CI 0.88-1.40), with hyperchloraemia in 31.4% versus 49.0%. A double-blind trial of 120 mechanically ventilated adults in two Melbourne ICUs found low-dose ketamine 0.15 mg/kg/hr reduced median hourly opioid dose from 77 to 64 microgram/hr fentanyl equivalents (median difference -13.0, 95% credible interval -26.6 to 2.4; probability of benefit 95.1%), with no difference in delirium. In 1,028 emergency department patients with acute nontraumatic headache, adding 2 g intravenous magnesium sulfate to paracetamol raised treatment success from 65.1% to 78.9% and halved rescue analgesia, though all pain-score differences fell below the accepted threshold for clinical importance. The FDA has recalled atropine sulfate injection for particulate contamination.

In this edition
01
Clinical update

Balanced fluid did not beat 0.9% saline in paediatric septic shock, in a trial big enough to settle it

Use whichever crystalloid is immediately available in paediatric septic shock; the choice did not change death, dialysis or kidney dysfunction across 8,482 children.

2 min · The New England journal of medicineRead →
Primary outcome
major adverse kidney event (death, new renal-replacement therapy or persistent kidney dysfunction) at 30 days or discharge
Effect
3.4% with balanced fluid vs 3.0% with 0.9% saline (difference 0.4 percentage points, 95% CI -0.5 to 1.3; RR 1.10, 0.88-1.40); hyperchloraemia 31.4% vs 49.0%
02Research

Low-dose ketamine cut hourly opioid requirement in ventilated adults without more delirium

Low-dose ketamine at 0.15 mg/kg/hr reduces opioid requirement in ventilated adults and did not increase delirium — a reasonable adjunct, not yet a proven benefit.

2 min · Critical care medicineRead →
03Clinical update

Intravenous magnesium for acute headache: more patients met the success threshold, but the pain scores barely moved

Intravenous magnesium added to paracetamol halves the need for rescue analgesia in acute headache, but do not promise the patient a large fall in pain.

2 min · Annals of emergency medicineRead →
04Regulatory

Class II recall of atropine sulfate injection for particulate contamination

Audit resuscitation trolleys and airway boxes against the recalled atropine lots; the pharmacy shelf is not where this drug is stored.

2 minRead →
05Pearl

When a patient on vasopressors suddenly deteriorates, look at the line before you turn up the dose

Before escalating a vasopressor for sudden hypotension, trace the line by hand — delivery failure looks identical to refractory shock and is commoner.

1 minRead →
06
Practice changer

Sodium bicarbonate corrected the acidosis and changed nothing that mattered

Stop giving sodium bicarbonate to correct metabolic acidosis in vasopressor-dependent patients; it did not reduce death, dialysis or renal dysfunction.

2 min · The New England journal of medicineRead →
Primary outcome
major adverse kidney event (death, renal-replacement therapy or persistent renal dysfunction) within 30 days
Effect
40.2% vs 39.4% (adjusted difference 1.2 percentage points, 95% CI -7.1 to 9.4; P = 0.78); renal-replacement therapy 16.8% vs 20.9%; 30-day in-hospital mortality 25.4% vs 24.0%

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free